Today is #WorldNTDDay! This year and every year, DOLF is committed to the goal of global elimination for onchocerciasis and lymphatic filariasis.

Join the WashU Global Health Center April 30th-May 1st for two days of inspiring plenaries, panels, and networking opportunities. Learn from experts in the field and gain insights into the impact of global health research conducted @WashUpubhealth Info> l8r.it/FHq2

Congratulations to DOLF on 15 years of research to eliminate river blindness and lymphatic filariasis! #beatNTDs #StampOutOncho #EliminateLF dolfproject.wustl.edu

DOLF is making news! WashU spoke to our DOLF team about their new publication showcasing the effects of moxidectin combination treatments for lymphatic filariasis. Read more here: medicine.washu.edu/news/a-faster-…

Earlier this month, DOLF hosted our 15th Anniversary Symposium in St. Louis. We celebrated past achievements, the people who've made them possible, and looked forward towards our goal of eliminating onchocerciasis and lymphatic filariasis. Thank you to all who were able to join!

DOLF recently lost Dr. Edward B. Guizie, our clinical ophthalmologist in Bong Mines, Liberia. Dr. Guizie was a beloved and dedicated member of the team and he will be greatly missed. dolfproject.wustl.edu/dolf-mourns-th…

Our molecular helminthology investigators, led by Dr. Sarah Greene, developed a valuable new diagnostic tool for onchocerciasis or river blindness. Read about it in the new article in the American Journal of Tropical Medicine and Hygiene! ajtmh.org/view/journals/…

We wish Dr. Gary Weil all the best as he embarks on the next stage of his long and fruitful career: retirement!

Last month, DOLF team members attended the AAVP Annual Meeting in St. Louis! Dr. Irina Diekmann presented a One Health approach to eliminating LF, and Dr. Lucia Sanchez Di Maggio presented on identifying DNA repeats of Paragonimus kellicotti.

This summer, DOLF hosted Dr. Peter McCarthy as a WashU School of Public Health MPH practicum student. Dr. McCarthy analyzed and compared onchocerciasis data from Liberia and Ghana, and assisted in writing a clinical trial protocol for an upcoming study in Liberia.

Rishika Mallu, a WashU undergraduate, joined the DOLF lab this summer to identify onchocerciasis presence in blackflies from Cote d’Ivoire. Her work will help us understand if MDA led to a measurable reduction in O. volvulus DNA in blackflies in that region.

Congratulations to DOLF collaborator, Prof. Taniawati Supali, for receiving the Sarwono Award! She was given the prestigious award for her work to support the elimination of lymphatic filariasis in Indonesia. dolfproject.wustl.edu/congratulation…

DOLF is hiring! We’re looking for a postdoctoral research associate in NTDs to perform lab research on helminth parasites, to assist in clinical trials for river blindness treatment, and to manage large data sets. See the WashU Jobs site for more info! sites.wustl.edu/dolfproject/wo…

DOLF Director of Clinical Research Dr. Philip Budge provided expertise on parasitic infectious diseases on St. Louis Public Radio earlier this month stlpr.org/health-science…

This publication is now in print in The Lancet Infectious Dieases! thelancet.com/journals/lanin…

DOLF postdoc, Dr. Irina Diekmann, published a new paper on the impact of animal reservoirs on lymphatic filariasis in Indonesia. Read more here! dolfproject.wustl.edu/impact-of-anim…

Catch DOLF in Toronto ASTMH 2025! Find our session information here: dolfproject.wustl.edu/dolf-is-headin…

DOLF had a successful trip to ASTMH 2025! Many engaging presentations, lively conversations, and discussions about the future of NTD treatment and elimination. Thanks to all the collaborators that we connected with in Toronto. Let's keep this important work going!

Check out our new DOLF publication! This study demonstrates that semi-annual and annual DEC and albendazole are both equally effective treatments for LF in Papua New Guinea. Read more about this discovery here: pubmed.ncbi.nlm.nih.gov/41336638/

DOLF is encouraged by this recommitment to the global elimination of LF, and we’re proud to be a part of this ongoing effort.